Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease (gfx350, 2018)
Year: 2018
Type: article
Authors: Dekkers, CCJ, Wheeler, DC, Sjostrom, CD, Stefansson, BV, Cain, V, Heerspink, HJL
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7028156406
